)
Trinity Biotech (TRIB) investor relations material
Trinity Biotech Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Offering details and pricing
Registered 705,659,320 Class A ordinary shares, previously represented by 35,282,966 ADSs, each ADS initially representing 20 ordinary shares.
On July 24, 2026, the ADS ratio changed to one ADS representing 600 ordinary shares, equivalent to a one-for-thirty reverse ADS split.
After the ratio change, 1,176,099 ADSs represented the same number of underlying ordinary shares.
A Standby Equity Purchase Agreement allowed for the sale of ADSs up to $25 million in gross proceeds.
The offering was terminated on July 7, 2026, with 675,048,580 ordinary shares (1,125,081 ADSs) removed from registration.
Use of proceeds and capital allocation
The Standby Equity Purchase Agreement provided an option to raise up to $25 million in gross proceeds through ADS sales.
Management team and governance
John Gillard, Chief Executive Officer, signed the filing on behalf of the company.
- Revenue up 43%, net loss halved, and major HIV test orders boost 2026 outlook.TRIB
Q1 2026 - Flexible $25M equity facility offers capital but poses major dilution risk for shareholders.TRIB
Registration filing - Up to 33.8M ADSs may be sold for $25M, supporting operations but increasing dilution risk.TRIB
Registration filing - Debt conversion enables up to 167.95M new ADSs, causing dilution but reducing liabilities.TRIB
Registration filing - Revenue fell and net loss widened, but gross margin and adjusted EBITDA improved.TRIB
Q4 2025 - Up to $25M in equity financing via ADS offering supports diagnostics growth amid high leverage and Nasdaq risks.TRIB
Registration filing - Revenue and margins declined in Q1 2025, but a strong rebound is expected in Q2.TRIB
Q1 2025 - Q3 revenue up 3%, Point-of-Care up 60%, and profitability initiatives progressing.TRIB
Q3 2024 - Q2 revenue up 14%, Point-of-Care sales surged 119%, and CGM development advanced toward pivotal trials.TRIB
Q2 2024
Next Trinity Biotech earnings date
Next Trinity Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)